Our previous studies24–26 found that pre-treatment with proton pump inhibitors (PPIs) can significantly inhibit the expression of V-ATPase in GC cell line SGC7901, and reverse multidrug resistance in GC through the down-regulation of PI3K/AKT/mTOR signaling pathway. The gene discussed is AKT1; the disease is gastric cancer.